Search research articles
Contact Us
Filters
Showing results (111-120 of 114) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 114 results.
Annals of Hematology
|
March 9, 2006
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, A Pluta, et al.
The Journal of Clinical Investigation
|
February 8, 2022
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
Gabriel Duette, Bonnie Hiener, Hannah Morgan, et al.
Leukemia & Lymphoma
|
August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia
T Robak, M Błasinka-Morawiec, E Krykowski, et al.
Bone Marrow Transplantation
|
July 10, 2002
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group
J Czyz, A Hellmann, R Dziadziuszko, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 114) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 114 results.
Annals of Hematology
|
March 9, 2006
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG)
A Wrzesień-Kuś, T Robak, A Pluta, et al.
The Journal of Clinical Investigation
|
February 8, 2022
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
Gabriel Duette, Bonnie Hiener, Hannah Morgan, et al.
Leukemia & Lymphoma
|
August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia
T Robak, M Błasinka-Morawiec, E Krykowski, et al.
Bone Marrow Transplantation
|
July 10, 2002
High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group
J Czyz, A Hellmann, R Dziadziuszko, et al.
Page
of 12